Pheon Therapeutics logo

Pheon Therapeutics

Antibody-Drug Conjugate specialist creating treatments for tough-to-treat cancers.

3

Funding Rounds

$256.0m

Money raised

Overview

Antibody-Drug Conjugate specialist creating treatments for tough-to-treat cancers.

Funding

Funding series

Funding Series Analysis

The company Pheon Therapeutics has raised a total of $256m in funding over 3 rounds.

Key Insights:

  • Pheon Therapeutics May 2024 Series B Funding Round: $120m
  • Pheon Therapeutics - Series A round, September 2022: $68m
  • Pheon Therapeutics September 2022 Series A Funding Round: $68m
Pheon Therapeutics logo
Pheon Therapeutics May 2024 Series B Funding Round $120m
Pheon Therapeutics logo
Pheon Therapeutics - Series A round, September 2022 $68m
Pheon Therapeutics logo
Pheon Therapeutics September 2022 Series A Funding Round $68m

Industries

Pheon Therapeutics is active in the following industries: